1. Home
  2. TWST vs CERT Comparison

TWST vs CERT Comparison

Compare TWST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$40.36

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$9.18

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
CERT
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
TWST
CERT
Price
$40.36
$9.18
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$44.67
$12.78
AVG Volume (30 Days)
1.2M
2.3M
Earning Date
02-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$376,572,000.00
$415,551,000.00
Revenue This Year
$15.19
$10.80
Revenue Next Year
$15.10
$6.47
P/E Ratio
N/A
$138.82
Revenue Growth
20.32
11.47
52 Week Low
$23.30
$8.03
52 Week High
$55.33
$15.69

Technical Indicators

Market Signals
Indicator
TWST
CERT
Relative Strength Index (RSI) 71.61 49.37
Support Level $34.55 $9.10
Resistance Level $37.73 $9.87
Average True Range (ATR) 1.79 0.28
MACD 0.59 0.07
Stochastic Oscillator 93.96 42.39

Price Performance

Historical Comparison
TWST
CERT

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: